Economic Analyses alongside Cancer Clinical Trials

Authored by: Dean A. Regier , Scott D. Ramsey

Handbook of Statistics in Clinical Oncology

Print publication date:  March  2012
Online publication date:  March  2012

Print ISBN: 9781439862001
eBook ISBN: 9781439862018
Adobe ISBN:

10.1201/b11800-27

 Download Chapter

 

Abstract

The ever-increasing cost of cancer care, combined with the high prevalence and economic burden of cancer in economically developed societies, has fostered a strong demand for economic information regarding new technologies aimed at the prevention, detection, and treatment of cancer. As efforts to control health care spending become increasingly intense, decision makers are forced to confront the reality that adopting new, cost-increasing technologies necessitates spending less in other areas of health care, which may adversely affect health outcomes. In this context, some have argued that it is reasonable to consider health outcomes and costs for cancer treatments relative to the health outcomes and costs for other medical interventions. The most common approach to compare the relative value of different interventions in creating better health and/or longer life is cost-effectiveness analysis (CEA) [1].

 Cite
Search for more...
Back to top

Use of cookies on this website

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more in our Privacy Policy. By continuing to use the site you are agreeing to our use of cookies.